Polypox A/S: Financial statements 2024
CVR: 40683321
Polypox A/S (CVR 40683321) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 1,950,557 and a net result of DKK 1,401,234 compared with DKK 899,434 the year before. That is an increase of 51.5% compared with the year before. Equity amounted to DKK 2,476,477. The solvency ratio was 52.2%.
- Gross Profit
- 1,950,557 kr.
- Profit/Loss
- 1,401,234 kr.
- Equity
- 2,476,477 kr.
- Total Assets
- 4,747,294 kr.
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 2 mio. | 1.4 mio. | 2.5 mio. | 0 |
| 2023 | - | 1.3 mio. | 899 t. | 1.9 mio. | 0 |
| 2022 | - | 791 t. | 494 t. | 2.3 mio. | - |
| 2021 | - | 1.8 mio. | 1.3 mio. | 2 mio. | - |
How creditworthy is Polypox A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2024
Polypox A/S has published its annual report for 2023. Gross profit came to DKK 1,287,902, and the net result was DKK 899,434.
As of June 25, 2024, Martin Jensen has joined the board of directors of Polypox A/S.
About Polypox A/S
Polypox A/S is a Danish company of the type Aktieselskab based in Videbæk, founded in 2019. The company is registered under the industry Udførelse af gulvbelægninger og vægbeklædning. The management consists of Christian Grønbæk Jensen. The company's owners include FLORIDANES A/S, Møllemarken Holding ApS and Jensen & Knipchildt Holding ApS. In 2025, the company reported a gross profit of DKK 7,611,054 and a net result of DKK 2,389,508 compared with DKK 1,401,234 the year before. Equity amounted to DKK 3,465,985.
